Here is some info on zolgensma, the drug that is apparently putting a dent in spinraza sales. Another gene therapy now most expensive ever. Interesting though that they claim it is a once off application that effectively fixes the issue permanently.
https://www.npr.org/sections/health-shots/2019/05/24/725404168/at-2-125-million-new-gene-therapy-is-the-most-expensive-drug-ever
Novartis set the price at $2.125 million but offers insurers the ability to pay $425,000 a year for five years. This price tag makes Zolgensma the most expensive drug ever approved.
The drug is delivered as a single one-time dose to address the genetic root cause of the disorder, the company says, producing long-term effects.
- Forums
- ASX - By Stock
- PYC
- Ann: 2019 AGM Presentation
PYC
pyc therapeutics limited
Add to My Watchlist
0.00%
!
$1.16

Ann: 2019 AGM Presentation, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
0.000(0.00%) |
Mkt cap ! $676.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 20403 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 1117 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 77891 | 1.150 |
1 | 50000 | 1.140 |
1 | 6756 | 1.130 |
1 | 889 | 1.125 |
3 | 9261 | 1.100 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 563 | 1 |
1.190 | 10000 | 1 |
1.200 | 2500 | 1 |
1.205 | 2270 | 1 |
1.220 | 5596 | 2 |
Last trade - 10.09am 17/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online